... were secondary endpoints. Results: Across 13 studies, in the context of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), 2,226 eyes received anti-VEGF monotherapy and 3,022 received faricimab. Final and change in BCVA were similar...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Extended depth of focus intraocular lens Epiretinal membrane Age-related macular degeneration The immediate result of a monofocal...

... Visual acuity Anti-vascular endothelial growth factor Age-related macular degeneration Retinal vein occlusion Diabetic macular edema Anti-vascular endothelial growth factor (anti-VEGF) therapy is indicated in several conditions, including neovascular age-related macular degeneration (nAMD...

...) autofluorescence (qAF) findings in a large pseudophakic cohort at age-related macular degeneration (AMD)’s beginnings and to assess qAF8 as an outcome measure and evaluate Age-Related Eye Disease Study (AREDS) and Beckman grading systems. Methods: In the ALSTAR2 baseline cohort (NCT04112667), 346 pseudophakic eyes...

...Daniele Veritti; Valentina Sarao; Deborah Martinuzzi; Sara Menzio; Paolo Lanzetta Background: Submacular hemorrhage (SMH) associated with neovascular age-related macular degeneration (nAMD) precipitates rapid visual decline and impacts quality of life. Treatments vary, but combined recombinant...

...Christoph R. Clemens; Nicole Eter; Florian Alten Background: The aim of this review was to systematically summarize the current knowledge on type 3 macular neovascularization (MNV3) in age-related macular degeneration (AMD). Summary: Recent histopathologic and multimodal imaging findings led...

...Zofia Anna Nawrocka; Jerzy Nawrocki Introduction: Submacular hemorrhage (SMH) is a vision-threatening complication of neovascular age-related macular degeneration (AMD). The exact treatment scheme is not established yet. The aim of the current study was to describe surgical results and fundus...

...]) in neovascular age-related macular degeneration (nAMD). The aims of this retrospective study were to determine the proportion of nAMD eyes treated ≥ Q12W, to analyze their longitudinal, functional, and anatomical outcomes, and to compare functional and anatomical outcomes between eyes that rapidly versus slowly...

...Damla Oncel; Deniz Oncel; Kapil Mishra; Murat Oncel; J. Fernando Arevalo Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss among individuals aged 65 years and older in the USA. For individuals diagnosed with AMD, approximately 12% experience varying levels...

...-associated retinal diseases such as age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinal vein occlusion compared with control patients. Results: In serum samples, miR-29a-3p and miR-192-5p showed increased expression in patients with neovascular AMD relative to control patients...

... nata or treat-and-extend [TAE]), according to macular neovascularization (MNV) subtype, on the functional and anatomical response in neovascular age-related macular degeneration (nAMD). The secondary objective was to compare the treatment burden between each MNV subtype. Methods: Consecutive treatment...

... in neovascular age-related macular degeneration (nAMD). This post hoc analysis of the CANTREAT trial explores the relationship between the maximal extension interval tolerated by patients receiving T&E ranibizumab and visual acuity outcomes. Methods: Treatment-naïve patients with nAMD were randomized...

... the early efficacy and safety of treatment with intravitreal injections (IVIs) of brolucizumab in patients presenting with neovascular age-related macular degeneration (nAMD) in a real-world setting. Methods: This retrospective study included 194 eyes of 180 patients with nAMD treated with standard 6-mg...

... Retinal pigment epithelium and outer retinal atrophy Age-related macular degeneration Dry age-related macular degeneration Exudative age-related macular degeneration Non-exudative macular neovascularization Age-related macular degeneration (AMD) is a degenerative disease that affects...

...Carl Regillo; Rishi Singh; Robin Hamilton; Kinfemichael Gedif; Catherine Best; Adrian Koh; Frank G. Holz Introduction: Neovascular age-related macular degeneration (nAMD) is characterized by exudation of fluid from abnormally growing blood vessels in the macula. Anti-vascular endothelial growth...

...Dana Zvi; Dinah Zur; Shula Schwartz; Shai Cohen; Avi Saranga; Anat Loewenstein; Michaella Goldstein Introduction: The increasing high prevalence of neovascular age-related macular degeneration (nvAMD) in the aging population combined with the need for frequent monitoring and treatment for many...

...Thomas Richard Johansen Forshaw; Yousif Subhi; Sten Andréasson; Torben Lykke Sørensen Background: The aim of this study was to systematically review the literature and to perform meta-analyses on full-field electroretinography (ffERG) between healthy controls and age-related macular degeneration...

... bevacizumab (IVB) injections for age-related macular degeneration (AMD) patients with peripapillary choroidal neovascularization (PPCNV). Methods: The study involved a retrospective case series of consecutive patients diagnosed with PPCNV secondary to AMD. All patients were treated with IVB injections...

...Alexander Foss; Tryfon Rotsos; Theo Empeslidis; Victor Chong Age-related macular degeneration (AMD) is a leading cause of blindness. Late AMD can be classified into exudative (commonly known as wet AMD [wAMD]) or dry AMD, both of which may progress to macular atrophy (MA). MA causes irreversible...

... for RPE-choroid TS included complications of neovascular age-related macular degeneration in 34 patients and drusenoid pigment epithelial detachment in 2 patients. With a mean follow-up of 30 months, 8 patients out of 36 developed signs of MNV. Of these 8 patients, 4 presented with a drop in visual acuity...